Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Population Cohort Study

NCT07198191 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT07198191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07198191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Population Cohort Study
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2014
Completion date
August 30, 2026
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction (ami), type 2 diabetes mellitus (t2dm)